Anti Ageing Drugs Companies | Market Research Future

Top Industry Leaders in the Anti Ageing Drugs Market

*Disclaimer: List of key companies in no particular orderLatest Anti-aging drug Companies Update

Aug 2023: The XEOMIN (incobotulinumtoxinA) drug from Merz Therapeutics has been permitted a new indication by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) to treat focal spasticity of the lower limbs that affects the ankle joint. The procedure was previously authorized in the UK to treat spasticity in the upper limbs. Thanks to the increased permission, the company can now offer comprehensive care to anyone with spasticity who requires it. IncobotulinumtoxinA is the active component of XEOMIN. To increase muscle tone, it is intramuscularly administered. Therapy reduces the strength of voluntary muscular contraction by blocking nerve signals to the muscles. It reduces aberrant muscular tone by preventing the release of acetylcholine from peripheral nerve terminals. According to Merz Therapeutics, XEOMIN is now suitable to treat the lower and upper limbs separately by adjusting the dose as required.

Sep 2023: Procter & Gamble India, a manufacturer of FMCG products, on Thursday unveiled a Rs 300 crore fund to work with outside partners and innovators to co-create solutions for a contemporary supply chain ecosystem. According to a statement from the company, the P&G Supply Chain Catalyst Fund would give startups and innovators the chance to work with Procter & Gamble (P&G) India on tailoring business solutions, speeding its progress towards Supply 3.0 ambitions. This is a portion of the Rs 1,800 crore dedicated to business solutions via vGROW, in which the company that makes products under the Gillette, Whisper, and Vicks brands invests in startups, established companies, and people and groups offering cutting-edge solutions.

List of Anti-aging drug Key companies in the market